NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT04083235,"A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment",https://clinicaltrials.gov/study/NCT04083235,NAPOLI 3,COMPLETED,"The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxaliplatin compared to nab-paclitaxel + gemcitabine treatment in improving the overall survival of patients not previously treated for metastatic pancreatic cancer.",YES,Metastatic Adenocarcinoma of the Pancreas,DRUG: Irinotecan Liposomal Injection|DRUG: Oxaliplatin|DRUG: 5Fluorouracil|DRUG: Leucovorin|DRUG: Nab-paclitaxel|DRUG: Gemcitabine,"Overall Survival (OS), The OS was defined as time from the date of randomization to the date of death due to any cause. Participants who did not have a date of death recorded at the time of the final analysis were censored at the last known time that the participant was alive. The median OS was measured using Kaplan-Meier technique., Assessments performed at baseline (within 28 days before start of study treatment), every 8 weeks after first dose, end of treatment (EoT) visit, then every 2 months thereafter up to DCO date of 23 July 2022 (maximum of 893 days)","Progression Free Survival (PFS), PFS was defined as the time from the date of randomization to the first documented disease progression using response evaluation criteria in solid tumors (RECIST) Version 1.1 as per Investigator assessment or death due to any cause. The median PFS was measured using Kaplan-Meier technique., Assessments performed at baseline (within 28 days before start of study treatment), every 8 weeks after first dose until EoT visit (maximum of 893 days)|Overall Response Rate (ORR), The ORR was defined as the percentage of participants with a best overall response (BOR) characterized as either a complete response (CR) or partial response (PR) per RECIST Version 1.1. BOR was defined as the best response as recorded from randomization until documented objective disease progression using RECIST Version 1.1. As per RECIST version 1.1, CR is disappearance of all target lesions; PR is \>=30% decrease in the sum of the longest diameter of target lesions; and overall response = CR + PR. The ORR was calculated using Clopper-Pearson method., Assessments performed at baseline (within 28 days before start of study treatment), every 8 weeks after first dose until EoT visit, (maximum of 893 days)",,Ipsen,,ALL,"ADULT, OLDER_ADULT",PHASE3,770,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,D-US-60010-001|2018-003585-14,2020-02-11,2022-07-23,2025-02-18,2019-09-10,2024-03-13,2025-03-25,"University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States|Banner Health- MD Anderson Cancer Center, Gilbert, Arizona, 85234, United States|Mayo Clinic - Scottsdale, Phoenix, Arizona, 85054, United States|Comprehensive Blood And Cancer Center, Bakersfield, California, 93309, United States|University of California- Irvine Health Cancer Cente, Costa Mesa, California, 92627, United States|City of Hope National Medical Center, Duarte, California, 91010, United States|University of California, Los Angeles (UCLA), Los Angeles, California, 90095, United States|St. Jude Hospital Yorba Linda dba St. Joseph Heritage Healthcare, Orange, California, 92835, United States|University of California - Irvine Medical Center, Orange, California, 92868, United States|Torrance Memorial Physician Network Cancer Care, Redondo Beach, California, 90277, United States|Sutter Health Sacramento, Sacramento, California, 95816, United States|Presbyterian Intercommunity Hospital (PIH), Whittier, California, 90602, United States|UC Health Memorial Hospital, Colorado Springs, Colorado, 80909, United States|Rocky Mountain Cancer Center, Denver, Colorado, 80218, United States|Mount Sinai Medical Center of Florida, Inc., Miami Beach, Florida, 33140, United States|Miami Cancer Institute, Miami, Florida, 33176, United States|Florida Cancer Specialists - Fort Myers, Sarasota, Florida, 34236, United States|Florida Cancer Specialists - Panhandle, Tallahassee, Florida, 32308, United States|Florida Cancer Specialists - St. Petersburg, Tampa, Florida, 33607, United States|Florida Cancer Specialists - East, West Palm Beach, Florida, 33401, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|Edward Hospital - Elmhurst, Elmhurst, Illinois, 60540, United States|Illinois CancerCare - Peoria, Peoria, Illinois, 61443, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, 46804, United States|Siouxland Hematology - Oncology Associates, LLP, Sioux City, Iowa, 51101, United States|University of Kentucky Markey Cancer Center, Lexington, Kentucky, 40536, United States|Pikeville Medical Center, Pikeville, Kentucky, 41501, United States|Hematology Oncology Clinic, Baton Rouge, Louisiana, 70809, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, 70121, United States|Willis-Knighton Cancer Center, Shreveport, Louisiana, 71103, United States|Maine Center for Cancer Medicine, Scarborough, Maine, 04074, United States|Maryland Oncology Hematology, Silver Spring, Maryland, 20904, United States|Beth Israel Deaconess, Boston, Massachusetts, 02215, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Cancer and Hematology Centers of Western Michigan, Grand Rapids, Michigan, 49546, United States|Health Partners Institute, Minneapolis, Minnesota, 55425, United States|Mayo Clinic - Rochester, Rochester, Minnesota, 55902, United States|Research Medical Center, Kansas City, Missouri, 64132, United States|Frontier Cancer Center, Billings, Montana, 59102, United States|Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha, Nebraska, 68130, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|Clinical Research Alliance, Inc, Lake Success, New York, 10021, United States|David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|University of Rochester, Rochester, New York, 14642, United States|Stony Brook University Medical Center, Stony Brook, New York, 11794, United States|Messino Cancer Center, Asheville, North Carolina, 28806, United States|The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - James), Columbus, Ohio, 43210, United States|Toledo Clinic Cancer Center, Toledo, Ohio, 43623, United States|University of Oklahoma - Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Oncology Associates of Oregon, Eugene, Oregon, 97401, United States|Compass Oncology - Rose Quarter Cancer Center, Portland, Oregon, 97227, United States|Kaiser Permanente - Northwest, Portland, Oregon, 97227, United States|Oregon Health & Science University (OHSU), Portland, Oregon, 97239, United States|University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|Greenville Hospital System, Greenville, South Carolina, 29605, United States|Chattanooga Oncology Hematology Care - Tennessee Oncology, Chattanooga, Tennessee, 37404, United States|The West Cancer Center, Memphis, Tennessee, 38138, United States|Sarah Cannon and HCA Research Institute, Nashville, Tennessee, 37203, United States|Texas Oncology - Austin, Austin, Texas, 78731, United States|Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States|The Center for Cancer and Blood Disorders, Fort Worth, Texas, 76104, United States|Baylor College of Medicine, Houston, Texas, 77030, United States|Houston Methodist Research Institute, Houston, Texas, 77030, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Oncology Consultants, Houston, Texas, 77030, United States|Texas Oncology - Tyler, Tyler, Texas, 75702, United States|Texas Oncology - Wichita Falls, Wichita Falls, Texas, 76310, United States|Utah Cancer Specialists, Salt Lake City, Utah, 84106, United States|Virginia Cancer Specialists, Fairfax, Virginia, 22031, United States|Blue Ridge Cancer Care, Wytheville, Virginia, 24014, United States|Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Bankstown-Lidcombe Hospital, Bankstown, 2200, Australia|Monash Medical Centre, Clayton, 3168, Australia|Fiona Stanley Hospital, Murdoch, 6150, Australia|Sir Charles Gairdner Hospital, Nedlands, 6009, Australia|St John of God Subiaco Hospital, Subiaco, 6008, Australia|Queen Elizabeth Hospital, Woodville South, 5011, Australia|Medizinische Universitaet Graz, Graz, 8036, Austria|Ordensklinikum Linz GmbH Barmherzige Schwestern, Linz, 4010, Austria|SCRI-CCCIT Gemeinnutzige Gmbh- Gemeinnutzige Salzburger Landeskliniken Betriebsgesmbh, Salzburg, A-5020, Austria|Medical University of Vienna, Vienna, 1090, Austria|Onze-Lieve-Vrouwziekenhuis, Aalst, 9300, Belgium|ASBL Grand Hôpital de Charleroi (GHdC), Site Notre Dame, Charleroi, 6000, Belgium|Universitair Ziekenhuis Antwerpen (UZA), Edegem, 2650, Belgium|University Hospital Gent, Gent, 9000, Belgium|Hospital centre Jolimont, Haine-Saint-Paul, 7100, Belgium|University Hospital (UZ) Leuven, Leuven, 3000, Belgium|University Hospital Mont-Godinne, Yvoir, 5530, Belgium|Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, 14784-400, Brazil|Centro Regional Integrado de Oncologia (CRIO), Ceara, 60336-550, Brazil|Instituto de Oncologia do Parana - IOP, Curitiba, 80530-010, Brazil|Centro de Pesquisas Oncológicas - CEPON, Florianópolis, 88034-000, Brazil|Hospital de Caridade de Ijui, Ijuí, 98700, Brazil|Clinica Neoplasias Litoral, Itajaí, 88301-220, Brazil|Hospital Bruno Born, Lajeado, 95900, Brazil|Centro de Pesquisas Clinicas de Natal - CPCLIN, Natal, 59025-050, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil|Instituto Nacional Do Cancer (INCA), Rio de Janeiro, 20230-130, Brazil|Instituto COI, Rio De Janeiro, 22793-080, Brazil|Instituto Brasileiro de Controle do Cancer - IBCC (Sao Paulo), San Paolo, 03102-006, Brazil|CIP Centro Integrado de Pesquisas do Hospital de Base, São José Do Rio Preto, 5416, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, 01323-001, Brazil|Instituto do Cancer do Estado de São Paulo (ICESP), São Paulo, Brazil|Alberta Health Services Cross Cancer Institute, Edmonton, T6G 1Z2, Canada|Queen Elizabeth II Health Sciences Centre, Halifax, B3H 3A7, Canada|McGill University Faculty of Medicine - Royal Victoria Hospital, Montréal, H3G 1Y6, Canada|Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, J1H 5N4, Canada|Masarykuv onkologicky ustav, Brno, 65653, Czechia|Fakultni nemocnice Hradec Kralove, Hradec Králové, 50005, Czechia|University Hospital Olomouc, Department of Oncology, Olomouc, 77020, Czechia|Thomayerova Nemocnice, Praha, 14059, Czechia|CHRU de Tours - Hôpital Trousseau, Chambray-lès-Tours, 37170, France|Centre Oscar Lambret, Lille, 59020, France|Hôpital Edouard Herriot, Lyon, 69003, France|Centre Leon Berard, Lyon, 69008, France|Hopital Prive Jean Mermoz, Lyon, 69008, France|Centre Antoine-Lacassagne, Nice, 06189, France|Hopital Saint Louis, Paris, 75010, France|CHU Bordeaux - Hopital Haut-Leveque, Pessac, 33604, France|Centre Hospitalier Universitaire de Poitiers - Poitiers University Hospital, Poitiers Cedex, 86021, France|Strasbourg Oncologie Liberale, Strasbourg, 67000, France|Charité - Universitaetsmedizin Berlin, Berlin, 10117, Germany|St. Josef-Hospital, Bochum, 44791, Germany|Klinikum Esslingen GmbH, Esslingen, 73730, Germany|Krankenhaus Nordwest, Frankfurt, 60488, Germany|Studiengesellschaft BSF, Halle, 06108, Germany|Martin Luther Universitat Halle-Wittenberg, Halle, 06120, Germany|Facharztzentrum Eppendorf, Hamburg, 20249, Germany|Marienkrankenhaus Hamburg, Hamburg, 22087, Germany|Asklepios Klinik Altona, Hamburg, 22763, Germany|Medizinische Hochschule Hannover, Hannover, 30625, Germany|Slk-Kliniken, Heilbronn, 74078, Germany|Klinikum Mannheim, Mannheim, 68167, Germany|Krankenhaus St. Franziskus - Kliniken Maria Hilf GmbH, Mönchengladbach, 41063, Germany|Universitaetsklinikum Tuebingen, Tuebingen, 72076, Germany|Universitaetsklinikum Ulm, Ulm, 89081, Germany|Agios Savvas Anticancer Hospital, Athens, 11522, Greece|General Hospital of Athens - Laiko, Athens, 11528, Greece|National and Kapodistrian University of Athens, Athens, 11528, Greece|University General Hospital of Ioannina, Ioánnina, 45500, Greece|Theagenion Hospital, Thessaloníki, 54007, Greece|Dél-pesti Centrumkórház - Szent László Kórház telephely, Budapest, 1097, Hungary|Országos Onkológiai Intézet, Budapest, 1122, Hungary|Semmelweis Egyetem Belgyógyászati és Hematológiai Klinika, Budapest, H-1089, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, H-4032, Hungary|Somogy Megyei Kaposi Mor Oktato Korhaz, Kaposvár, 7400, Hungary|Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Rendelointézet, Szolnok, H-5000, Hungary|Soroka Medical Center, Beer Sheva, Beer Sheva, Israel|Rambam Health Care Campus, Haifa, 3109601, Israel|Policlinico S. Orsola-Malpighi, Bologna, 40138, Italy|Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, 47014, Italy|Istituto Europeo di Oncologia, Milano, 20141, Italy|Azienda Ospedaliero-Universitaria di Modena, Modena, 41124, Italy|AUSL di Piacenza-Ospedale Guglielmo Da Saliceto, Piacenza, 29121, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, 56126, Italy|AOU Ospedali Riuniti di Ancona, Torrette, 60126, Italy|Azienda Ospedaliera - Universitaria Integrata di Verona - Ospedale Borgo Roma, Verona, 37134, Italy|Inje University Haeundae Paik Hospital, Busan, 48108, Korea, Republic of|National Cancer Center, Goyang-si, 10408, Korea, Republic of|CHA Bundang Medical Center, Gyeonggi-do, 13520, Korea, Republic of|Asan Medical Center, Seoul, 05505, Korea, Republic of|Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, 06591, Korea, Republic of|Korea University Guro Hospital, Seoul, 08308, Korea, Republic of|Hospital de Braga, Braga, 4710-243, Portugal|Centro Hospitalar Universitario de Lisboa Norte - Hospital de Santa Maria, Lisboa, 1649-035, Portugal|Champalimaud Cancer Center, Lisbon, 1400-038, Portugal|Unidade Local de Saude Matosinhos E.P.E. Hospital Pedro Hispano, Senhora da Hora, 4464-513, Portugal|Centro Hospitalar de Vila Nova de Gaia/Espinho EPE, Vila Nova de Gaia, 4434-502, Portugal|Evimed LLC, Chelyabinsk, 454048, Russian Federation|Limited Liability Company- Clinica Druzhkovyh, Kazan, 420126, Russian Federation|Kursk Regional Clinical Oncology Dispensary, Kursk, 305524, Russian Federation|Main Military Clinical Hospital named after N.N. Burdenko, Moscow, 105229, Russian Federation|Volga District Medical Centre, Novgorod, 603074, Russian Federation|Federal State Budgetary Institution - Russian Scientific Center of Radiology and Surgical Technologies n.a. academician A.M.Granov, Saint-Petersburg, Russian Federation|Hospital General Universitario de Elche, Alicante, 03203, Spain|Hospital Universitario de Badajoz, Badajoz, 06080, Spain|Hospital Germans Trias i Pujol, Badalona, 08916, Spain|Hospital Quironsalud Barcelona, Barcelona, 08023, Spain|Hospital de la Santa Creu i Sant Pau Barcelona, Barcelona, 08026, Spain|Hospital Vall D Hebron, Barcelona, 08035, Spain|Hospital Clinic Barcelona, Barcelona, 08036, Spain|Corporacio Sanitaria Parc Tauli - Hospital de Sabadell, Barcelona, 08208, Spain|Institut Catala d'Oncologia - L'Hospitalet, Barcelona, 08908, Spain|Complejo Hospitalario Universitario de Granada - Hospital Universitario Virgen de las Nieves, Granada, 18014, Spain|Hospital General Universitario Gregorio Marañon, Madrid, 28007, Spain|Fundacion Jimenez Diaz, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Centro Integral Oncologico Clara Campal, Madrid, 28050, Spain|Hospital Regional Universitario de Malaga, Málaga, 29009, Spain|Complejo Hospitalario de Navarra, Pamplona, 31008, Spain|Hospital Universitario Marques de Valdecilla, Santander, 39008, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain|Guy's and St. Thomas' NHS Foundation Trust, London, SE1 9RT, United Kingdom|Royal Marsden Foundation Trust, London, SM2 5PT, United Kingdom|Royal Marsden Foundation Trust, London, SW3 6JJ, United Kingdom|Imperial College Healthcare NHS Trust, London, W12 0HS, United Kingdom|Cancer Research UK - Christie Hospital Foundation NHS Trust - Dept of Medical Oncology, Manchester, M20 4BX, United Kingdom|Nottingham City Hospital, Nottingham, NG5 1PB, United Kingdom","Study Protocol, https://cdn.clinicaltrials.gov/large-docs/35/NCT04083235/Prot_002.pdf|Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/35/NCT04083235/SAP_001.pdf"
